As of 2025-10-23, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is (4.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 93.76 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -104.9%.
The range of the Relative Valuation is (3.65) - (5.47) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 8.0x - 11.9x | 10.0x |
| Fair Price | (3.65) - (5.47) | (4.56) |
| Upside | -103.9% - -105.8% | -104.9% |
| Date | P/E |